Discrepancies in surgical rates for CD are observed between population-based studies and referral cohorts. As medical therapy advances further, temporal trends in rates of surgical ostomy creation need to be re-evaluated.
Ma et al. conducted a population-based surveillance using the Discharge Abstract Database of the Calgary Health Zone [13]. Data for the period between April 1, 2002 and March 31, 2009 were included. Patients aged ≥18 years were identified who were admitted for CD and underwent surgical stoma creation (n=427).
The overall stoma creation rate was 1.9 stomas per 100 person-years (95% CI: 1.5-2.5). The rate of stoma creation between 2002 and 2009 trended downwards by an average of 5.8% per year (95% CI: −11.4%, 0.2%). It decreased from 2.3 stomas per 100 person-years (95% CI: 1.8-3.0) in 2002 to 1.6 stomas per 100 person-years (95% CI: 1.3-2.1) in 2009. When stratified by surgical indication, the rate of emergency-ostomy creation decreased significantly from 2002 to 2009, with an annual change of −14.6% (95% CI: −22.8-−5.6%). In contrast, elective-ostomy creation rate remained stable with an annual change of 3.1% (95% CI: −2.8-9.4%).
At the beginning of the study period, emergency-stoma creation rate exceeded elective-stoma creation rate (1.3 emergency stomas vs. 1.0 elective stomas per 100 person-years). By the end of the study period, this pattern had reversed (0.6 emergency stomas vs. 1.1 elective stomas per 100 person-years).
The frequency of emergency compared with elective stoma surgery was observed to shift between 2005 and 2006. Thus, this large population-based study showed a significant reduction in the rate of emergency-stoma surgeries for CD. A paradigm shift in surgical care trended towards increasing the rate of elective-stoma creation during the biologic era.
- Ma C, et al. DOP039. ECCO 2018.
Posted on
Previous Article
« Apremilast in active UC shows promising results Next Article
Long-term safety profile of adalimumab »
« Apremilast in active UC shows promising results Next Article
Long-term safety profile of adalimumab »
Table of Contents: ECCO 2018
Featured articles
IBD diagnostics
IBD disease patterns and genetics
Novel treatment strategies
Efficacy and safety of biologics
Oncology in IBD
Surgery for IBD
Related Articles
May 28, 2018
Letter from The Editor
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy